Grifoni Alba, Sette Alessandro
Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI), La Jolla, CA, 92037, USA.
Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California, San Diego (UCSD), La Jolla, CA, 92037, USA.
Curr Res Immunol. 2022;3:146-150. doi: 10.1016/j.crimmu.2022.08.005. Epub 2022 Aug 10.
It is critically important to understand how the adaptive immune response, elicited by vaccination or infection, recognizes SARS-CoV-2. This is especially true when considering the challenges to the immune response posed by variant evolution. Herein, we summarize our work aimed at characterizing the magnitude of the CD4 and CD8 T cell responses to SARS-CoV-2, the proteins most frequently recognized, and the associated T cell epitope repertoire. This work formed the foundation for our most recent studies aimed at understanding and predicting the ability of T cell responses induced by SARS-CoV-2 infection or vaccination to subsequently cross-recognize novel SARS-CoV-2 variants. We found that T cell responses are remarkably preserved and able to cross-recognize SARS-CoV-2 variants, from Alpha to Omicron. This is distinct from what has been observed for the SARS-CoV-2- specific antibody and B cell responses. This body of work, supported by independent studies carried out by other groups, suggests that T cells may contribute to a second line of defense against infection while also limiting viral spread and, thus, disease severity.
了解由疫苗接种或感染引发的适应性免疫反应如何识别新型冠状病毒至关重要。在考虑变异进化对免疫反应带来的挑战时,情况尤其如此。在此,我们总结了我们的工作,旨在表征针对新型冠状病毒的CD4和CD8 T细胞反应的强度、最常被识别的蛋白质以及相关的T细胞表位库。这项工作为我们最近的研究奠定了基础,这些研究旨在理解和预测由新型冠状病毒感染或疫苗接种诱导的T细胞反应随后交叉识别新型冠状病毒变体的能力。我们发现,T细胞反应得到了显著保留,并且能够交叉识别从阿尔法到奥密克戎的新型冠状病毒变体。这与新型冠状病毒特异性抗体和B细胞反应的情况不同。这项工作得到了其他团队开展的独立研究的支持,表明T细胞可能有助于形成针对感染的第二道防线,同时还能限制病毒传播,从而减轻疾病严重程度。